Cipla is trading lower by 2.2% to Rs 396 after reporting a lower-than-expected 25.5% year-on-year (yoy) growth in net profit at Rs 339 crore for the third quarter ended December 31, 2012 (Q3). Analysts on an average had expected profit of Rs 374 crore from the drug maker.
Gross revenues grew by 18% to Rs 2,103 crore from Rs 1,783 crore in the corresponding quarter of previous year, driven mainly by the domestic performance.
“The company’s operating profit grew by 25.4% at Rs 493 crore on yoy basis, while operating margins improved 140 basis points at 23.44% during the recently concluded quarter,” Cipla said in a statement.
The stock opened at Rs 397 and hit a low of Rs 394 on the National Stock Exchange. A combined around 980,000 shares have changed hands on the counter in opening deals on both the exchanges.
Gross revenues grew by 18% to Rs 2,103 crore from Rs 1,783 crore in the corresponding quarter of previous year, driven mainly by the domestic performance.
“The company’s operating profit grew by 25.4% at Rs 493 crore on yoy basis, while operating margins improved 140 basis points at 23.44% during the recently concluded quarter,” Cipla said in a statement.
The stock opened at Rs 397 and hit a low of Rs 394 on the National Stock Exchange. A combined around 980,000 shares have changed hands on the counter in opening deals on both the exchanges.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%